Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation

Liu,Jia; Zhao,Zehang; Sun,Zhiwei; Liu,Chang; Cheng,Xiaojing; Ruge,Fiona; Yang,Yong; Jiang,Wen  G.; Ye,Lin

doi:10.3892/or.2019.7445

Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation

Authors:
- Jia Liu
- Zehang Zhao
- Zhiwei Sun
- Chang Liu
- Xiaojing Cheng
- Fiona Ruge
- Yong Yang
- Wen G. Jiang
- Lin Ye
View Affiliations

Affiliations: Cardiff China Medical Research Collaborative, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK, Key Laboratory of Carcinogenesis and Translational Research, Department of Urological Surgery, Peking University Cancer Hospital and Institute, Beijing 100142, P.R. China
Published online on: December 24, 2019 https://doi.org/10.3892/or.2019.7445
Pages: 562-570
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Psoriasin, otherwise known as S100A7, is a member of the S100 protein family. With the key function of binding calcium, it is able to regulate a range of cellular functions. Altered Psoriasin expression is associated with poor clinical outcomes in several solid cancers. The present study aimed to examine the implication of Psoriasin in bladder cancer (BC). Expression of Psoriasin was examined in BC cell lines using PCR. Immunohistochemical (IHC) staining of Psoriasin was performed on a bladder disease spectrum tissue array. Plasmids were constructed to effectively knockdown and overexpress Psoriasin in BC cells and further utilized for in vitro BC cellular function assays. Association between Psoriasin expression and survival of patients with BC was evaluated using Kaplan‑Meier survival analysis. Psoriasin was revealed to be expressed by both bladder epithelia and cancer cells as determined by IHC. Increased expression of Psoriasin was significantly correlated with a poor overall BC patient survival. Overexpression of Psoriasin in the EJ138 cell line increased cellular proliferation, adhesion and invasion, whereas knockdown exhibited the opposite effect on cellular functions in RT112 cells. Matrix metalloprotease (MMP)9 appeared to be the most affected of the three MMPs examined in these two BC cell lines. The analysis revealed a positive correlation in BC tumours between Psoriasin and MMP9. Overall, high Psoriasin expression was correlated with poor overall survival in BC patients and promoted invasiveness of BC cells via upregulation of MMPs. Psoriasin possesses certain prognostic and therapeutic potential in BC which requires further exploration.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Droller MJ: Bladder cancer: State-of-the-art care. CA Cancer J Clin. 48:269–284. 1998. View Article : Google Scholar : PubMed/NCBI
3	Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H and Bostwick DG: Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 88:2326–2332. 2000. View Article : Google Scholar : PubMed/NCBI
4	Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
5	Madsen P, Rasmussen HH, Leffers H, Honoré B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et al: Molecular cloning, occurrence, and expression of a novel partially secreted protein ‘psoriasin’ that is highly up-regulated in psoriatic skin. J Invest Dermatol. 97:701–712. 1991. View Article : Google Scholar : PubMed/NCBI
6	Algermissen B, Sitzmann J, LeMotte P and Czarnetzki B: Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch Dermatol Res. 288:426–430. 1996. View Article : Google Scholar : PubMed/NCBI
7	Salama I, Malone PS, Mihaimeed F and Jones JL: A review of the S100 proteins in cancer. Eur J Surg Oncol. 34:357–364. 2008. View Article : Google Scholar : PubMed/NCBI
8	Jiang WG, Watkins G, Douglas-Jones A and Mansel RE: Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes. Int J Oncol. 25:81–85. 2004.PubMed/NCBI
9	Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M and Glaser R: Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol. 133:253–261. 2007. View Article : Google Scholar : PubMed/NCBI
10	Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R and Siu KW: Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One. 5:e119392010. View Article : Google Scholar : PubMed/NCBI
11	Ye L, Sun PH, Martin TA, Sanders AJ, Mason MD and Jiang WG: Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urol Oncol. 31:1576–1583. 2013. View Article : Google Scholar : PubMed/NCBI
12	Hu M, Ye L, Ruge F, Zhi X, Zhang L and Jiang WG: The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions. BMC Cancer. 12:5882012. View Article : Google Scholar : PubMed/NCBI
13	Emberley ED, Alowami S, Snell L, Murphy LC and Watson PH: S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res. 6:R308–R315. 2004. View Article : Google Scholar : PubMed/NCBI
14	Shubbar E, Vegfors J, Carlstrom M, Petersson S and Enerback C: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Res Treat. 134:71–80. 2012. View Article : Google Scholar : PubMed/NCBI
15	Sneh A, Deol YS, Ganju A, Shilo K, Rosol TJ, Nasser MW and Ganju RK: Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling. Breast Cancer Res Treat. 138:727–739. 2013. View Article : Google Scholar : PubMed/NCBI
16	Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H and Celis JE: Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res. 57:4111–4117. 1997.PubMed/NCBI
17	Celis JE, Rasmussen HH, Vorum H, Madsen P, Honoré B, Wolf H and Orntoft TF: Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol. 155:2105–2112. 1996. View Article : Google Scholar : PubMed/NCBI
18	Ostergaard M, Wolf H, Orntoft TF and Celis JE: Psoriasin (S100A7): A putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas. Electrophoresis. 20:349–354. 1999. View Article : Google Scholar : PubMed/NCBI
19	Rasmussen HH, Orntoft TF, Wolf H and Celis JE: Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol. 155:2113–2119. 1996. View Article : Google Scholar : PubMed/NCBI
20	Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, Møller K and Ørntoft TF: Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 64:4040–4048. 2004. View Article : Google Scholar : PubMed/NCBI
21	Lindgren D, Sjödahl G, Lauss M, Staaf J, Chebil G, Lövgren K, Gudjonsson S, Liedberg F, Patschan O, Månsson W, et al: Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma. PLoS One. 7:e388632012. View Article : Google Scholar : PubMed/NCBI
22	Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
23	Oyasu R: World health organization and international society of urological pathology classification and two-number grading system of bladder tumors. Cancer. 88:1509–1512. 2000. View Article : Google Scholar : PubMed/NCBI
24	Glaser R, Harder J, Lange H, Bartels J, Christophers E and Schroder JM: Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol. 6:57–64. 2005. View Article : Google Scholar : PubMed/NCBI
25	Liu Y, Bunston C, Hodson N, Resaul J, Sun PH, Cai S, Chen G, Gu Y, Satherley LK, Bosanquet DC, et al: Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. Int J Oncol. 50:1491–1500. 2017. View Article : Google Scholar : PubMed/NCBI
26	Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, Mao Y, Li M, Peng A, He D and Xiao X: Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax. 63:352–359. 2008. View Article : Google Scholar : PubMed/NCBI
27	Winston J and Wolf R: Psoriasin (S100A7) promotes migration of a squamous carcinoma cell line. J Dermatol Sci. 67:205–207. 2012. View Article : Google Scholar : PubMed/NCBI
28	Ellenrieder V, Alber B, Lacher U, Hendler SF, Menke A, Boeck W, Wagner M, Wilda M, Friess H, Büchler M, et al: Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer. 85:14–20. 2000. View Article : Google Scholar : PubMed/NCBI
29	Morgan MR, Jazayeri M, Ramsay AG, Thomas GJ, Boulanger MJ, Hart IR and Marshall JF: Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. Oncogene. 30:1422–1435. 2011. View Article : Google Scholar : PubMed/NCBI